TGFB2 and prostate cancer: Both TGFb2 and GDF10 ligands bind TGFb3R to increase nuclear translocation of (active) phospho-p38 [41, 54], which deepens quiescence in prostate cancer cells by promoting expression of the CKI p27 [55].